Shares of Biodexa Pharmaceuticals Plc (LON:MTPH – Get Free Report) passed below its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of GBX 18 ($0.24) and traded as low as GBX 12.50 ($0.16). Biodexa Pharmaceuticals shares last traded at GBX 18 ($0.24), with a volume of 73,672 shares.
Biodexa Pharmaceuticals Stock Performance
The company has a quick ratio of 5.28, a current ratio of 5.28 and a debt-to-equity ratio of 9.52. The firm has a market cap of £31.20 million, a P/E ratio of -21.95 and a beta of 1.22. The business has a fifty day simple moving average of GBX 18 and a 200-day simple moving average of GBX 18.
About Biodexa Pharmaceuticals
Midatech Pharma plc, a drug delivery technology company, focuses on the research and development of medicines in the United Kingdom, rest of Europe, and internationally. The company is developing MTX110, a direct delivery treatment for diffuse intrinsic pontine glioma, medulloblastomas, and glioblastoma multiforme; MTX114, an immuno-suppressant for topical application in psoriasis; MTD211, a long-acting formulation of brexpiprazole for the treatment of schizophrenia and adjunctive treatment of major depressive disorder; and MTD219, a long-acting formulation of tacrolimus used to lower the risk of organ transplant rejection.
Featured Stories
- Five stocks we like better than Biodexa Pharmaceuticals
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- Goldman Sachs Earnings Reveal Market Moves Investors Can’t Ignore
- What is the Shanghai Stock Exchange Composite Index?
- AMD Gains Momentum With AI: Can It Beat Expectations?
- How to Start Investing in Real Estate
- Lithium Grab: 2 Lithium Stocks That Could Be Takeover Targets
Receive News & Ratings for Biodexa Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biodexa Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
